CIK 0000908259 · Non-accelerated filer<br>Smaller reporting company
Oncotelic Therapeutics, Inc.
Sign in to watch- Ticker
- OTLC
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133679168
- Phone
- 650-635-7000
- Business address
- 29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
- Former names
- MATEON THERAPEUTICS INC, OXIGENE INC
- Open-market buys, last 90 days
- $23,537
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$23,537. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-01-02 | DRISCOLL FREDERICK W Director | Grant or award · Stock Option (Right to Buy) | +7,310 | 7,310 | ||
| 2014-01-02 | DRISCOLL FREDERICK W Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2013-08-08 | LANGECKER PETER Chief Executive Officer | Grant or award | +72,993 | 77,993 | ||
| 2013-07-01 | Wood Alastair JJ Director | Grant or award · Stock Option (Right to Buy) | +890 | 890 | ||
| 2013-07-01 | CHAPLIN DAVID Director | Grant or award · Stock Option (Right to Buy) | +10,060 | 10,060 | ||
| 2013-07-01 | Schwieterman William D Director | Grant or award · Stock Option (Right to Buy) | +10,060 | 10,060 | ||
| 2013-07-01 | McMahon Gerald PhD Director | Grant or award | +7,407 | 11,180 | ||
| 2013-07-01 | HOWSON TAMAR D Director | Grant or award | +3,703 | 8,761 | ||
| 2013-07-01 | HOWSON TAMAR D Director | Grant or award · Stock Option (Right to Buy) | +5,030 | 5,030 | ||
| 2013-06-28 | LANGECKER PETER Chief Executive Officer | Purchase | +3,000 | $2.75 | $8K | 5,000 |
| 2013-06-25 | LANGECKER PETER Chief Executive Officer | Purchase | +2,000 | $2.79 | $6K | 2,000 |
| 2013-02-27 | RICHING BARBARA CFO | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2013-02-27 | LANGECKER PETER Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +8,333 | 8,333 | ||
| 2013-01-23 | CHAPLIN DAVID Director | Grant or award · Stock Option (Right to Buy) | +6,260 | 6,260 | ||
| 2013-01-02 | HOWSON TAMAR D Director | Grant or award | +1,886 | 5,058 | ||
| 2013-01-02 | HOWSON TAMAR D Director | Grant or award · Stock Option (Right to Buy) | +2,570 | 2,570 | ||
| 2013-01-02 | McMahon Gerald PhD Director | Grant or award | +3,773 | 3,773 | ||
| 2013-01-02 | Schwieterman William D Director | Grant or award · Stock Option (Right to Buy) | +5,140 | 5,140 | ||
| 2013-01-02 | Wood Alastair JJ Director | Grant or award · Stock Option (Right to Buy) | +5,140 | 5,140 | ||
| 2012-07-30 | LANGECKER PETER Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 |
Page 7 of 7 · 140 trades